跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Sitampex - Philippines FDA Drug Approval Details
Approvals
/
Philippines FDA
/
Sitampex
Approved
STANDARD
Sitampex
Reyoung Pharmaceutical Co., LTD.
🇵🇭 Food and Drug Administration - Philippines
Approval Date
Jul 14, 2025
Approval ID
a61ba354b2e0b34e
Company
Reyoung Pharmaceutical Co., LTD.
Type
Standard
Approval Details
Approval Id
a61ba354b2e0b34e
Drug Approval Philippines Name
Sitampex
Product Name
Sitampex
Registration Number
DR-XY49230
Brand Name
Sitampex
Generic Name
Ampicillin (as sodium) + Sulbactam (as sodium) + Sulbactam (as sodium)
Dosage Form
Powder for Injection (I.M./I.V.)
Dosage Strength
1 g/500 mg
Manufacturer
Reyoung Pharmaceutical Co., LTD.
Importer
Sahar International Trading Inc.
Distributor
Sahar International Trading Inc.
Issuance Date
25 September 2024
Expiry Date
25 September 2029
Pharmacologic Category
Antibacterial (Penicillin/Beta-lactamase Inhibitor)
Classification
Prescription Drug (RX)
Active Ingredients
Approved
Quick Info
Agency
Philippines FDA
Country
🇵🇭
Approval Date
Jul 14, 2025
Approval ID
a61ba354b2e0b34e
Type
Standard
Back to Philippines FDA Approvals